糖尿病性足潰瘍(DFU)治療の世界市場:規模・現状・予測2019-2025

QYResearchが発行した調査報告書(QYR20FB13574)
◆英語タイトル:Global Diabetic Foot Ulcer (DFU) Treatment Market Size, Status and Forecast 2019-2025
◆商品コード:QYR20FB13574
◆発行会社(リサーチ会社):QYResearch
◆発行日:2019年11月21日(※2024年版があります。お問い合わせください。)
◆ページ数:96
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※当調査レポートでは、糖尿病性足潰瘍(DFU)治療の世界市場について調査・分析し、糖尿病性足潰瘍(DFU)治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別(創傷ケアドレッシング、生物製剤、治療機器、抗生物質治療、その他)、用途別(神経障害性潰瘍、虚血性潰瘍、神経虚血性潰瘍)、地域別(北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米)に区分して市場規模を算出しました。


・レポートの概要
・世界の糖尿病性足潰瘍(DFU)治療市場動向
・主要企業別マーケットシェア
・糖尿病性足潰瘍(DFU)治療の種類別市場規模2014-2019
(創傷ケアドレッシング、生物製剤、治療機器、抗生物質治療、その他)
・糖尿病性足潰瘍(DFU)治療の用途別市場規模2014-2019
(神経障害性潰瘍、虚血性潰瘍、神経虚血性潰瘍)
・糖尿病性足潰瘍(DFU)治療の北米市場:主要企業・種類別/用途別市場規模
・糖尿病性足潰瘍(DFU)治療のヨーロッパ市場:主要企業・種類別/用途別市場規模
・糖尿病性足潰瘍(DFU)治療の中国市場:主要企業・種類別/用途別市場規模
・糖尿病性足潰瘍(DFU)治療の日本国内市場:主要企業・種類別/用途別市場規模
・糖尿病性足潰瘍(DFU)治療の東南アジア市場:主要企業・種類別/用途別市場規模
・糖尿病性足潰瘍(DFU)治療のインド市場:主要企業・種類別/用途別市場規模
・糖尿病性足潰瘍(DFU)治療の中南米市場:主要企業・種類別/用途別市場規模
・主要企業のプロフィール
(ConvaTec、Acelity、Coloplast、3 M、Smith & Nephew、B. Braun、Medline、Medtronic、Organogenesis、Molnlycke Health Care、BSN Medical)
・糖尿病性足潰瘍(DFU)治療の市場規模予測2019-2025
(種類別、用途別、地域別市場予測)
・アナリストの観点・結論
...
【レポートの概要】

Diabetic foot ulcer is a major complication of diabetes mellitus, and probably the major component of the diabetic foot.In 2018, the global Diabetic Foot Ulcer (DFU) Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Diabetic Foot Ulcer (DFU) Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Diabetic Foot Ulcer (DFU) Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
ConvaTec
Acelity
Coloplast
3 M
Smith & Nephew
B. Braun
Medline
Medtronic
Organogenesis
Molnlycke Health Care
BSN Medical

Market segment by Type, the product can be split into
Wound Care Dressings
Biologics
Therapy Devices
Antibiotic Medications
Others

Market segment by Application, split into
Neuropathic Ulcers
Ischemic Ulcers
Neuro-ischemic Ulcers

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Diabetic Foot Ulcer (DFU) Treatment status, future forecast, growth opportunity, key market and key players.
To present the Diabetic Foot Ulcer (DFU) Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Diabetic Foot Ulcer (DFU) Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Diabetic Foot Ulcer (DFU) Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Wound Care Dressings
1.4.3 Biologics
1.4.4 Therapy Devices
1.4.5 Antibiotic Medications
1.4.6 Others
1.5 Market by Application
1.5.1 Global Diabetic Foot Ulcer (DFU) Treatment Market Share by Application (2019-2025)
1.5.2 Neuropathic Ulcers
1.5.3 Ischemic Ulcers
1.5.4 Neuro-ischemic Ulcers
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Diabetic Foot Ulcer (DFU) Treatment Market Size
2.2 Diabetic Foot Ulcer (DFU) Treatment Growth Trends by Regions
2.2.1 Diabetic Foot Ulcer (DFU) Treatment Market Size by Regions (2019-2025)
2.2.2 Diabetic Foot Ulcer (DFU) Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Diabetic Foot Ulcer (DFU) Treatment Market Size by by Players
3.1.1 Global Diabetic Foot Ulcer (DFU) Treatment Revenue by by Players (2014-2019)
3.1.2 Global Diabetic Foot Ulcer (DFU) Treatment Revenue Market Share by by Players (2014-2019)
3.1.3 Global Diabetic Foot Ulcer (DFU) Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Diabetic Foot Ulcer (DFU) Treatment Key Players Head office and Area Served
3.3 Key Players Diabetic Foot Ulcer (DFU) Treatment Product/Solution/Service
3.4 Date of Enter into Diabetic Foot Ulcer (DFU) Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Diabetic Foot Ulcer (DFU) Treatment Market Size by Type (2014-2019)
4.2 Global Diabetic Foot Ulcer (DFU) Treatment Market Size by Application (2014-2019)

5 North America
5.1 North America Diabetic Foot Ulcer (DFU) Treatment Market Size (2014-2019)
5.2 Diabetic Foot Ulcer (DFU) Treatment Key Players in North America
5.3 North America Diabetic Foot Ulcer (DFU) Treatment Market Size by Type
5.4 North America Diabetic Foot Ulcer (DFU) Treatment Market Size by Application

6 Europe
6.1 Europe Diabetic Foot Ulcer (DFU) Treatment Market Size (2014-2019)
6.2 Diabetic Foot Ulcer (DFU) Treatment Key Players in Europe
6.3 Europe Diabetic Foot Ulcer (DFU) Treatment Market Size by Type
6.4 Europe Diabetic Foot Ulcer (DFU) Treatment Market Size by Application

7 China
7.1 China Diabetic Foot Ulcer (DFU) Treatment Market Size (2014-2019)
7.2 Diabetic Foot Ulcer (DFU) Treatment Key Players in China
7.3 China Diabetic Foot Ulcer (DFU) Treatment Market Size by Type
7.4 China Diabetic Foot Ulcer (DFU) Treatment Market Size by Application

8 Japan
8.1 Japan Diabetic Foot Ulcer (DFU) Treatment Market Size (2014-2019)
8.2 Diabetic Foot Ulcer (DFU) Treatment Key Players in Japan
8.3 Japan Diabetic Foot Ulcer (DFU) Treatment Market Size by Type
8.4 Japan Diabetic Foot Ulcer (DFU) Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Diabetic Foot Ulcer (DFU) Treatment Market Size (2014-2019)
9.2 Diabetic Foot Ulcer (DFU) Treatment Key Players in Southeast Asia
9.3 Southeast Asia Diabetic Foot Ulcer (DFU) Treatment Market Size by Type
9.4 Southeast Asia Diabetic Foot Ulcer (DFU) Treatment Market Size by Application

10 India
10.1 India Diabetic Foot Ulcer (DFU) Treatment Market Size (2014-2019)
10.2 Diabetic Foot Ulcer (DFU) Treatment Key Players in India
10.3 India Diabetic Foot Ulcer (DFU) Treatment Market Size by Type
10.4 India Diabetic Foot Ulcer (DFU) Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Diabetic Foot Ulcer (DFU) Treatment Market Size (2014-2019)
11.2 Diabetic Foot Ulcer (DFU) Treatment Key Players in Central & South America
11.3 Central & South America Diabetic Foot Ulcer (DFU) Treatment Market Size by Type
11.4 Central & South America Diabetic Foot Ulcer (DFU) Treatment Market Size by Application

12 International Players Profiles
12.1 ConvaTec
12.1.1 ConvaTec Company Details
12.1.2 Company Description and Business Overview
12.1.3 Diabetic Foot Ulcer (DFU) Treatment Introduction
12.1.4 ConvaTec Revenue in Diabetic Foot Ulcer (DFU) Treatment Business (2014-2019))
12.1.5 ConvaTec Recent Development
12.2 Acelity
12.2.1 Acelity Company Details
12.2.2 Company Description and Business Overview
12.2.3 Diabetic Foot Ulcer (DFU) Treatment Introduction
12.2.4 Acelity Revenue in Diabetic Foot Ulcer (DFU) Treatment Business (2014-2019)
12.2.5 Acelity Recent Development
12.3 Coloplast
12.3.1 Coloplast Company Details
12.3.2 Company Description and Business Overview
12.3.3 Diabetic Foot Ulcer (DFU) Treatment Introduction
12.3.4 Coloplast Revenue in Diabetic Foot Ulcer (DFU) Treatment Business (2014-2019)
12.3.5 Coloplast Recent Development
12.4 3 M
12.4.1 3 M Company Details
12.4.2 Company Description and Business Overview
12.4.3 Diabetic Foot Ulcer (DFU) Treatment Introduction
12.4.4 3 M Revenue in Diabetic Foot Ulcer (DFU) Treatment Business (2014-2019)
12.4.5 3 M Recent Development
12.5 Smith & Nephew
12.5.1 Smith & Nephew Company Details
12.5.2 Company Description and Business Overview
12.5.3 Diabetic Foot Ulcer (DFU) Treatment Introduction
12.5.4 Smith & Nephew Revenue in Diabetic Foot Ulcer (DFU) Treatment Business (2014-2019)
12.5.5 Smith & Nephew Recent Development
12.6 B. Braun
12.6.1 B. Braun Company Details
12.6.2 Company Description and Business Overview
12.6.3 Diabetic Foot Ulcer (DFU) Treatment Introduction
12.6.4 B. Braun Revenue in Diabetic Foot Ulcer (DFU) Treatment Business (2014-2019)
12.6.5 B. Braun Recent Development
12.7 Medline
12.7.1 Medline Company Details
12.7.2 Company Description and Business Overview
12.7.3 Diabetic Foot Ulcer (DFU) Treatment Introduction
12.7.4 Medline Revenue in Diabetic Foot Ulcer (DFU) Treatment Business (2014-2019)
12.7.5 Medline Recent Development
12.8 Medtronic
12.8.1 Medtronic Company Details
12.8.2 Company Description and Business Overview
12.8.3 Diabetic Foot Ulcer (DFU) Treatment Introduction
12.8.4 Medtronic Revenue in Diabetic Foot Ulcer (DFU) Treatment Business (2014-2019)
12.8.5 Medtronic Recent Development
12.9 Organogenesis
12.9.1 Organogenesis Company Details
12.9.2 Company Description and Business Overview
12.9.3 Diabetic Foot Ulcer (DFU) Treatment Introduction
12.9.4 Organogenesis Revenue in Diabetic Foot Ulcer (DFU) Treatment Business (2014-2019)
12.9.5 Organogenesis Recent Development
12.10 Molnlycke Health Care
12.10.1 Molnlycke Health Care Company Details
12.10.2 Company Description and Business Overview
12.10.3 Diabetic Foot Ulcer (DFU) Treatment Introduction
12.10.4 Molnlycke Health Care Revenue in Diabetic Foot Ulcer (DFU) Treatment Business (2014-2019)
12.10.5 Molnlycke Health Care Recent Development
12.11 BSN Medical

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

...

【掲載企業】

ConvaTec、Acelity、Coloplast、3 M、Smith & Nephew、B. Braun、Medline、Medtronic、Organogenesis、Molnlycke Health Care、BSN Medical

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 糖尿病性足潰瘍(DFU)治療の世界市場:規模・現状・予測2019-2025(Global Diabetic Foot Ulcer (DFU) Treatment Market Size, Status and Forecast 2019-2025)]についてメールでお問い合わせはこちらでお願いします。